Microglia activation in central nervous system disorders: A review of recent mechanistic investigations and

Jun Qin1, Zhihui Ma1, Xiaoli Chen1

  • 1Department of Anesthesiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Frontiers in Neurology
|March 24, 2023
PubMed

Insights

Microglia, the brain's immune cells, are key in central nervous system (CNS) disorders. Despite advances, clinical trials targeting microglia activation show no efficacy, highlighting a need for better mechanistic understanding.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia are the primary immune cells within the central nervous system (CNS).
  • They play critical roles in the pathogenesis and progression of various CNS disorders.
  • Recent research has improved understanding of microglia activation patterns and neuron interactions.

Purpose of the Study:

  • To review recent studies on microglia in CNS disorders.
  • To provide a mechanistic perspective on microglia activation, inflammation, and repair.
  • To contextualize the failure of current clinical trials.

Main Methods:

  • Literature review of recent studies on microglia.
  • Analysis of signaling pathways involved in microglia activation.
  • Synthesis of findings related to inflammation and tissue repair in CNS disorders.

Main Results:

  • Significant advancements in understanding microglia's temporal and spatial activation patterns.
  • Identification of multiple implicated signaling pathways in CNS disorders.
  • Consistent failure of all conducted clinical trials to show efficacy over placebo.

Conclusions:

  • Despite increased knowledge of microglia biology, therapeutic translation remains a challenge.
  • A deeper mechanistic insight is required for effective clinical interventions.
  • Future research should focus on translating mechanistic understanding into successful treatments for CNS disorders.

Related Concept Videos